Professor Amira Guirguis: key facts
- Kind of voice
- Academic
- Role
- Chief scientist at the Royal College of Pharmacy
- Quoted on
- Cancer, Respiratory (asthma/COPD)
- Tracked press citations
- 2
- Most recently quoted
- 30 Sept 2026
- First quoted
- 10 Sept 2026
“The Deloitte report highlights a major shift in pharmaceutical innovation, with GLP-1 obesity medicines now accounting for a much larger share of pipeline value and, for the first time in 16 years, overtaking oncology. This reflects strong scientific and commercial momentum in obesity research, while also raising important questions about balance across the wider innovation pipeline.”
What Professor Amira Guirguis has said
“Our recent survey found that almost 60% of pharmacists who responded believe patients are unaware of the risks of using these medicines longer than recommended. We support clearer product information and improved packaging, alongside consistent public messaging, to improve awareness that these products are for short-term use only and to avoid preventable harm.”
Chief scientist at the Royal College of Pharmacy · Respiratory (asthma/COPD) · 10 Sept 2026 · Nasal decongestant spray use limited to a maximum of five days by MHRA ↗
Where Professor Amira Guirguis has been quoted
- Obesity drugs replace oncology as highest value area for drug developmentpharmaceutical-journal.com · 30 Sept 2026
- Nasal decongestant spray use limited to a maximum of five days by MHRApulsetoday.co.uk · 10 Sept 2026
Related media coverage
Recent UK press coverage of their topics — not necessarily citing them directly.
- Can AI really predict cancer survival better than a doctor? I have my doubts | Devi SridharThe Guardian
- CHEST Investigations Explore COPD Guideline Adherence, Adding Ensifentrine, and Use of AI in EducationThe American Journal of Managed Care
- Lilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) CongressPR Newswire
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 5 Oct 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.